Zobrazeno 1 - 10
of 130
pro vyhledávání: '"Michael R. Abern"'
Autor:
Tara McCray, Julian V. Pacheco, Candice C. Loitz, Jason Garcia, Bethany Baumann, Michael J. Schlicht, Klara Valyi-Nagy, Michael R. Abern, Larisa Nonn
Publikováno v:
iScience, Vol 24, Iss 6, Pp 102640- (2021)
Externí odkaz:
https://doaj.org/article/4ad20eaa33274fef9c1fc2368d058451
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-9 (2017)
Abstract Background Current evidence on risk of prostate cancer following a diagnosis of male breast cancer is limited and guidance for screening in this potentially higher-risk population remainsunclear. Our objective was to quantify prostate cancer
Externí odkaz:
https://doaj.org/article/7e62dfd429b64d1b9db1801b51128461
Autor:
Michael R. Abern, Laurence A. Levine
Publikováno v:
The Scientific World Journal, Vol 9, Pp 665-675 (2009)
The purpose of our study was to outline the evaluation of the Peyronie's disease (PD) patient and review the available nonsurgical treatments. A review of the literature on oral, intralesional, external energy, iontophoresis, and mechanical therapies
Externí odkaz:
https://doaj.org/article/6d10335c65934529a864d1f4cfc5a5e4
Publikováno v:
Journal of Endourology. 36:1545-1550
Autor:
Srinath Kotamarti, Rajan T. Gupta, Bangchen Wang, Denis Séguier, Zoe Michael, Dylan Zhang, Michael R. Abern, Jiaoti Huang, Thomas J. Polascik
Publikováno v:
European Urology Oncology. 5:483-493
Publikováno v:
Minerva Surgery.
Autor:
Adriana C. Vidal, Michael R. Abern, Alessio Crippa, Luke Mittelstaedt, Hari T. Vigneswaran, Martin Eklund, Stephen J. Freedland
Publikováno v:
Prostate Cancer and Prostatic Diseases. 25:165-173
Several studies evaluated prostate cancer (PCa) outcomes in Black men on active surveillance (AS); most studies contained few Black men and results were conflicting. We performed a systematic review and meta-analyze of race and outcomes on AS. A syst
Autor:
Heidy Wang, Shoujin Wu, Adam B. Murphy, Michael R. Abern, Patrice King-Lee, Patricia Vidal, Lisa K. Sharp, Roohollah Sharifi, Karen Ferrer, Marlene Gallegos, Carol Estwing Ferrans, Li Liu, Marin Sekosan, Courtney M.P. Hollowell, Andre Kajdacsy-Balla, Peter H. Gann
Publikováno v:
Journal of Clinical Oncology. 39:1660-1670
PURPOSE The Genomic Prostate Score (GPS), performed on biopsy tissue, predicts adverse outcome in prostate cancer (PCa) and has shown promise for improving patient selection for active surveillance (AS). However, its impact on treatment choice in hig
Autor:
Daniel M. Moreira, Hari T. Vigneswaran, Jyotsna S. Jagai, Michael R. Abern, David T. Greenwald, Ryan W. Dobbs, Megh Kumar, Achal P. Patel
Publikováno v:
Prostate Cancer and Prostatic Diseases. 24:1129-1136
Prostate cancer (PC) etiology is up to 57% heritable, with the remainder attributed to environmental exposures. There are limited studies regarding national level environmental exposures and PC aggressiveness, which was the focus of this study METHOD
Autor:
John V. Dudinec, David I. Ortiz-Melo, Michael E. Lipkin, Michael R. Abern, Ankeet M. Shah, Brant A. Inman
Publikováno v:
Urologic oncology.
Renal function outcomes between radical nephroureterectomy (RNU) and nephron-sparing surgery (NSS) for upper tract urothelial carcinoma (UTUC) patients are not well established. We sought to compare the incidence and factors associated with developme